Our findings on the ability of miR-222 for regulating the expression of PCSK9, a LDLR negative regulator, is in line with its formerly identified roles in lipid metabolic diseases and susceptibility for developing obesity and heart failure. This evidence concerns the gene PCSK9 and Obesity.